Statement of Phlow Corp. on the Introduction of the “PREPARE Act”

2021, Corporate Statements

RICHMOND, Va.– Today Phlow™ Corp. released the following statement on the introduction of H.R. 5388, the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act of 2021 in the United States House of...

National Essential Medicine Shortage Awareness Day Highlights a Critical Public Health Issue that Demands America’s Attention

2021, Press Releases

RICHMOND, Va., September 8, 2021 – Phlow, a U.S.-based, essential medicines impact company, today announced its support of the first-ever National Essential Medicine Shortage Awareness Day. This observance was created to educate the public about the ongoing crisis of...

Observance Day Overview

2021, Other News

Phlow Corp. CEO Publishes Op-Ed in Harvard Business Review

2021, Phlow™ in the News

Source: Harvard Business Review Eric Edwards, M.D., Ph.D., co-founder, President, and CEO of Phlow, has published an op-ed titled “The U.S. Needs to Reimagine Its Pharma Supply Chain” in Harvard Business Review about essential medications currently in shortage. “When...

Phlow Corp. Receives The U.S Department of Health and Human Services, Office of Small and Disadvantaged Business Utilization, Small Business Prime Contractor of the Year Award

2021, Press Releases, Updates From Phlow™

RICHMOND, Va., July 19, 2021 – The U.S. Department of Health and Human Services (HHS), recently announced that Phlow Corp. has been awarded the Office of Small and Disadvantaged Business Utilization (OSDBU), Small Business Prime Contractor of the Year Award. Phlow...